These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy. Brachmann J, Ansari A, Mahla G, Handrock R, Klebs S. Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097 [Abstract] [Full Text] [Related]
12. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial. Pathak L, Hiremath, Kerkar PG, Manade VG. J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308 [Abstract] [Full Text] [Related]
13. An open, parallel, comparative evaluation of amlodipine and nitrendipine in the monotherapeutic treatment of mild and moderate essential hypertension. Englert R, Beressem P, von Manteuffel E, Stafunsky S, Kramar M. J Cardiovasc Pharmacol; 1991 Mar; 17 Suppl 1():S22-4. PubMed ID: 16296702 [Abstract] [Full Text] [Related]